Response-driven movement control with AUSTEDO1

Dial representing multiple dosing options up to 48 mg/day. In clinical trials, the average daily dose was >36 mg. Dial representing multiple dosing options up to 48 mg/day. In clinical trials, the average daily dose was >36 mg. Dial representing multiple dosing options up to 48 mg/day. In clinical trials, the average daily dose was >36 mg.

Therapeutic maintenance dosing for AUSTEDO starts at 24 mg/day.1

Please see additional dosing and administration information at the bottom of this page.

AUSTEDO dosing should increase until symptom control is effectively and tolerably achieved1

Start treatment at 12 mg/day

Blue arrow pointing right Blue arrow pointing right

Increase by 6 mg/day weekly1

Ascending bar graph to represent the titration schedule through Week 7. Ascending bar graph to represent the titration schedule through Week 7. Ascending bar graph to represent the titration schedule through Week 7.

AUSTEDO is available in 6-mg, 9-mg, and 12-mg tablets1

6 mg AUSTEDO®  (deutetrabenazine) tablet.9 mg AUSTEDO®  (deutetrabenazine) tablet. 12 mg AUSTEDO®  (deutetrabenazine) tablet.

Tablets not shown at actual size.

Purple glass icon.

Additional dosing and administration information1

  • Administer total daily dosages in 2 divided doses
  • AUSTEDO should be taken with food
  • AUSTEDO should be swallowed whole. Tablets should not be chewed, crushed, or broken
Purple video icon.

Watch TD Movements Over Time

See Charlene’s treatment journey—find information on titration and the effects on symptom control.

See Charlene’s treatment journey—find information on titration and the effects on symptom control.

REFERENCES: 1. AUSTEDO® (deutetrabenazine) tablets current Prescribing Information. Parsippany, NJ, Teva Neuroscience, Inc. 2. Data on file. Parsippany, NJ: Teva Neuroscience, Inc.